AlafuzofF, I., et al. 1987. Histopathological criteria for progressive dementia disorders: Clinical pathological correlation and classification by multivariate data analysis. Acta Neuropathologica 74: 209-25. Albert, M. T., R. G. Feldman, and A. L. Willis. 1974. The subcortical dementia of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry 37: 121-50. Albert, M. T., et al. 1984. CT density numbers in patients with senile dementia of the Alzheimer type. Archives of Neurology 41: 1264-9. Bartus, R. T., et al. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-17. Beach, Thomas G. 1987. The history of Alzheimer's disease: The debates. Journal of the History of Medicine and Allied Sciences 42: 327-49. Blessed, G., B. E. Tomlinson, and M. Roth. 1968. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 114: 797-811.

Brodie, J. A. 1982. An epidemiologist views senile dementia facts and fragments. American Journal of Epidemiology 115: 115-62. Christie, J. E., et al. 1981. Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer pre-

senile dementia. British Journal of Psychiatry 138: 46-50.

Cohen, E. L., and R. J. Wurtman. 1976. Brain acetylcholine: Control by dietary choline. Science 191: 561-2.

Cook, R. H., et al. 1979. Studies in aging of the brain: IV. Familial Alzheimer disease: relation of transmissible dementia, aneuploidy, and microtubular defects. Neurology 29: 1404-12.

Coyle, J. T., D. Price, and M. R. DeLong. 1983. Alzheimer's disease: A disorder of central cholinergic innervation. Science 219: 1184-9.

Cummings, J. L., and D. F. Benson. 1983. Dementia: A clinical approach. London.

Devanand, D. P., H. A. Sackeim, and R. Mayeux. 1988. Psychosis, behavioral disturbance, and the use of neuroleptics in dementia. Comprehensive Psychiatry 29: 387-401.

Eisdorfer, C., and D. Cohen. 1981. Management of the patient and family coping with dementing illness. Journal of Family Practice 12: 831-7.

Folstein, M. F., S. E. Folstein, and P. R. McHugh. 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12: 189-98.

Fox, T. H., J. L. Topel, and M. S. Huckman. 1975. Use of computerized tomography in senile dementia. Journal of Neurology, Neurosurgery and Psychiatry 38:948-53.

Gustafson, L., and L. Nilsson. 1982. Differential diagnosis of presenile dementia on clinical grounds. Acta Psychi-atrica Scandinavica 65: 194—209.

Harner, R. N. 1975. EEG evaluation of the patient with dementia. In Psychiatric aspects of neurologic disease, ed. D. F. Benson and D. Blumer, 63-82. New York.

Haxby, J. V., et al. 1986. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Archives of Neurology 43: 882-5.

Hersch, E. L. 1979. Development and application of the extended scale for dementia. Journal of the American Geriatrics Society 27: 348-54.

Heston, L. L., and A. R. Masri. 1966. The genetics of Alzheimer's disease: Associations with hematologic malignancy and Down's syndrome. Archives of General Psychiatry 34: 976-81.

Hughes, C. P., et al. 1982. A new clinical scale for the staging of dementia. British Journal of Psychiatry 140: 566-72.

Johnson, K. A., et al. 1987. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Archives of Neurology 44: 1075-80.

1988. Single photon emission computed tomography in Alzheimer's disease: Abnormal iofetamine I123 uptake reflects dementia severity. Archives of Neurology 45: 392-6.

Katzman, R. 1976. The prevalence in malignancy of Alzheimer's disease: A major killer (editorial). Archives of General Psychiatry 33: 217-18.

1986. Alzheimer's disease. New England Journal of Medicine 314: 964-73.

Kay, D. W. K., P. Beamish, and M. Roth. 1964. Old age mental disorders in Newcastle-upon-Tyne. British Journal of Psychiatry 110:146-8.

Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Archives of Neurology 42: 1097-105.

Kokmen, E. 1984. Dementia: Alzheimer type. Mayo Clinic Proceedings 59: 35-42.

Kral, B. A. 1962. Forgetfulness: Benign and malignant. Canadian Medical Association Journal. 86: 257—60.

Markesbery, W. R., et al. 1981. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Annals of Neurology 10: 511—16.

Marttila, R. J., and U. K. Rinne. 1976. Dementia in Parkinson's Disease. Acta Neurologica Scandinavica 54: 431-41.

Mayeux, R., Y. Stern, and S. Spanton. 1985. Clinical heterogeneity in patients with dementia of the Alzheimer type: Evidence for subgroups. Neurology 35: 453-61.

McKhann, G., et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939—44.

Morris, J. C., et al. 1988. Consortium to establish a registry for Alzheimer's disease. Psychopharmacology Bulletin 24: 641-52.

Mundy-Castle, A. C., et al. 1953. The electroencephalogram in the senile psychosis. Electroencephalography and Clinical Neurophysiology 6: 245-52.

Nuwer, M. R. 1988. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. Journal of Clinical Neurophysiology 5: 45-85.

Rabins, Peter V. 1988. Science and medicine in the spotlight: Alzheimer's disease as an example. Perspectives in Biology and Medicine 31: 161-9.

Reisberg, Barry. 1983. Alzheimer's disease. New York and London.

Reisberg, B., et al. 1982. The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia. American Journal of Psychiatry 139: 1136-9.

Reisberg, B., et al. 1983. The Brief Cognitive Rating Scale (BCRS): Findings in primary degenerative dementia. Psychopharmacology Bulletin 19: 47—50.

Reynolds, C. F., et al. 1983. Electroencephalographic sleep aging, and psychopathology: New data and state of art. Biological Psychiatry 18: 139—55.

Salzman, C., G. E. Kochansky, and R. I. Shader. 1972. Rating scales for geriatric psychopharmacology — a review. Psychopharmacology Bulletin 8: 3—50.

Schenk, N. K, B. Reisberg, and S. H. Ferris. 1982. An overview of current concepts of Alzheimer's disease. American Journal of Psychiatry 139: 165-73.

Seltzer, B., and I. Sherwin. 1983. A comparison of clinical features in early and late-onset primary degenerative dementia: One entity or two? Archives of Neurology 40: 143-6.

Sharp, P., et al. 1986. Application of iodine-I123 labeled isopropylamphetamine imaging to the study of dementia. Journal of Nuclear Medicine 27: 761—8.

Sojdel-Sulkhowska, E. M., and C. A. Marotta. 1984. Alzheimer's disease brain: Alterations in RNA levels and in a ribonuclease—inhibitor complex. Science 225: 947-9.

Spor, J. E., and R. Gerner. 1982. Does the dexamethasone suppression test distinguish dementia from depression? American Journal of Psychiatry 139: 238-40.

St. George-Hyslop, P. H., et al. 1987. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235: 885-90.

Stern, Y., M. Sano, and R. Mayeux. 1988. Long-term administration of oral physostigmine in Alzheimer's disease. Neurology 38: 1837-41.

Summers, W. K., et al. 1986. Oral tetrahydroamino-acridine in long-term treatment of senile dementia Alzheimer's disease. New England Journal of Medicine 315:1241-5.

Terry, R. D., et al. 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Annals of Neurology 10: 184-92.

Thai, L. J., et al. 1983. Oral physostigmine and lecithin improve memory in Alzheimer's disease. Annals of Neurology 13: 491-6.

Tierney, M. C., et al. 1988. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 38: 359-64.

Tomilson, D. E., G. Blessed, and M. Roth. 1968. Observations on the brains of non-demented old people. Journal of the Neurological Sciences 7: 331-56.

1970. Observations on the brains of demented old people. Journal of the Neurological Sciences 11: 205—32.

Vannoy, John E, and James A. Greene. 1989. Alzheimer's disease: A brief history. Journal of the Tennessee Medical Association 82: 15—17.

Visser, S. L., et al. 1976. Visual evoked response in senile and presenile dementia. Electroencephalography and Clinical Neurophysiology 40: 385-92.

Volicer L., and L. R. Herz. 1985. Pharmacologic management of Alzheimer-type dementia. American Family Physician 32: 123-8.

Watts, H., P. G. E. Kennedy, and M. Thomas. 1981. The significance of antineuronal antibodies in Alzheimer's disease. Journal of Neuroimmunology 1: 107-16.

Wells, C. E. 1977. Dementia. Philadelphia.

1979. Pseudodementia. American Journal of Psychiatry 136: 895-900.

Wettstein, A., and R. Spiegel. 1984. Clinical trials with the cholinergic drug RS86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer's type (SDAT). Psychopharmacology 84: 572-3.

Wisniewski, H. M. 1978. Possible viral etiology of neurofibrillary changes and neuritic plagues. In Alzheimer's disease: senile dementia and related disorders, ed. R. Katzman, R. D. Terry, and K. L. Beck, 355-8. New York.

1989. Alzheimer's disease and related disorders. New York.

Wurtman, R. J., M, J. Hirsch, and J. Growdon. 1977. Lecithin consumption raises serum free-choline levels. Lancet 2: 68-9.

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook

Post a comment